Corbus Pharmaceuticals Holdings (CRBP) Other Non-Current Liabilities (2016 - 2023)

Corbus Pharmaceuticals Holdings' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $44000.0 for Q4 2023.

• On a quarterly basis, Other Non-Current Liabilities rose 98.15% year-over-year to $44000.0 in Q4 2023; TTM through Dec 2023 was $44000.0, a 98.15% increase from a year earlier, with the FY2023 full-year figure at $44000.0, up 98.15% from the prior year.
• Other Non-Current Liabilities fell to $44000.0 in Q4 2023 per CRBP's latest filing, from $44410.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $2.5 million in Q1 2023 and bottomed at $797.0 in Q4 2020.
• The 4-year median for Other Non-Current Liabilities is $22205.0 (2021), against an average of $328741.7.
• Across the five-year window, Other Non-Current Liabilities sank 97.23% in 2022 and jumped 11258.73% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $797.0 in 2020, then jumped by 2686.07% to $22205.0 in 2021, then changed by 0.0% to $22205.0 in 2022, then surged by 98.15% to $44000.0 in 2023.
• Per Business Quant, the three latest CRBP Other Non-Current Liabilities figures stand at $44000.0 (Q4 2023), $44410.0 (Q3 2023), and $22205.0 (Q2 2023).